Skip to main content

U.S. approves digital pill that tracks when patients take it



U.S. regulators on Tuesday approved the first digital pill with an embedded sensor to track if patients are taking their medication properly, marking a significant step forward in the convergence of healthcare and technology.

The medicine is a version of Otsuka Pharmaceutical Co Ltd’s established drug, Abilify, for schizophrenia, bipolar disorder and depression, containing a tracking device developed by Proteus Digital Health.

The system offers doctors an objective way to measure if patients are swallowing their pills on schedule, opening up a new avenue for monitoring medicine compliance that could be applied in other therapeutic areas.

Shares in Otsuka rose 2.5 per cent, after news of the U.S. Food and Drug Administration late on Monday.

The FDA said that being able to track ingestion of medicines prescribed for mental illness may be useful “for some patients”, although the ability of the digital pill to improve patient compliance had not been proved.

“The FDA supports the development and use of new technology in prescription drugs and is committed to working with companies to understand how technology might benefit patients and prescribers,” said Mitchell Mathis of the FDA’s Centre for Drug Evaluation and Research.

The system works by sending a message from the pill’s sensor to a wearable patch, which then transmits the information to a mobile application so that patients can track the ingestion of the medication on their smartphone.

About the size of a grain of salt, the sensor has no battery or antenna and is activated when it gets wet from stomach juices.

That completes a circuit between coatings of copper and magnesium on either side, generating a tiny electric charge.

In the longer term, such digital pills could also be used to manage patients with other complicated medicine routines, such as those suffering from diabetes or heart conditions.

Poor compliance with drug regimens is a common problem in many disease areas, especially when patients suffer from chronic conditions.

Proteus has been working on the pill tracking system for many years and the sensor used in Abilify MyCite was first cleared for use by the FDA in 2012.

The unlisted Californian company has attracted investments from several large healthcare companies, including Novartis AG, Medtronic Inc and St. Jude Medical Inc, as well as Otsuka.

Abilify MyCite is not approved to treat patients with dementia-related psychosis.

It also contains a boxed warning alerting health care professionals that elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. (Reuters/NAN)


Labels:

Comments

Post a Comment

Comment here

Popular posts from this blog

Are you over 100? Then you've got a better chance of living even longer!

It’s considered an inescapable fact of life: the older you get, the more likely death becomes. But a new research conucted in Germany disproves of that suggestinh that the chances of dying may level off – at least for those who make it to 105 years old. The study found that death rates, which rise exponentially in adulthood, begin to decelerate after 80 years old and appear to eventually plateau, or even decline slightly, after the age of 105. By that point, the chances of passing away in a given year are approximately 50-50. “It’s the equivalent of tossing a coin each year,” said Prof Jim Vaupel, a specialist in ageing at the Max Planck Institute for Demographic Research in Germany and one of the authors. The findings add fuel to an unusually hostile debate between two camps of scientists, who are locked in an escalating dispute about whether humans are approaching their upper limit in terms of lifespan. The latest paper, from Vaupel’s team who argue there is no evidence of a loom...
Post a Comment
Read more

Michael Kors Buys Italy's Versace Fashion House For $2.12 Billion

Fashion company Michael Kors is buying Versace, the Italian luxury brand founded by Gianni Versace in 1978, for $2.12 billion. The two fashion houses made the announcement Tuesday, one day after speculation spread about a potential deal. Donatella Versace, the artistic director of the Milan-based fashion house who helped lead the company after her brother's death in 1997, said it's the perfect time for the company to join with Michael Kors. "It has been more than 20 years since I took over the company along with my brother Santo and daughter Allegra," Donatella Versace said in a news release. "I am proud that Versace remains very strong in both fashion and modern culture."
Post a Comment
Read more

UN condemns Plateau killings, AI says FG encouraging murderers

The Secretary-General of the United Nations, António Guterres, on Thursday expressed concern over violent conflicts between farmers and herders in countries across West and Central Africa, particularly the Plateau attacks that claimed the lives of over 86 villagers on Saturday. But the Amnesty International has said by failing to hold murderers to account, the Federal Government is encouraging impunity that is fuelling rising insecurity across the country. The Director Amnesty International Nigeria, Osai Ojigho, stated this in a report released by the international agency on Thursday. AI stated that its independently verified estimated figures indicated that since January 2018 “at least 1,813 people had been murdered in 17 states, which is double the 894 people killed in 2017.” Ojigho stated, “The death tolls reflect killings as a result of farmers-herders conflict, communal clashes, Boko Haram attacks and banditry. “We are gravely concerned about the rising spate of killings across...
Post a Comment
Read more